Literature DB >> 19524721

Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease.

Chi-Fu Jeffrey Yang1, Michele Lee, Clarissa Valim, Melissa A Hull, Jing Zhou, Brian A Jones, Kathy Gura, Sharon Collier, Clifford Lo, Christopher Duggan, Tom Jaksic.   

Abstract

BACKGROUND: Parenteral nutrition-associated liver disease (PNALD) is a serious condition affecting many children with short bowel syndrome. The aim of this study was to longitudinally assess serum alanine aminotransferase (ALT), a marker for hepatocyte injury, in enterally fed children with PNALD.
METHODS: Retrospective chart review of 31 patients treated from 1999 to 2006 by the Center for Advanced Intestinal Rehabilitation at Children's Hospital Boston (Mass). Inclusion criteria included PN duration of greater than 3 months with subsequent tolerance of full enteral nutrition and evidence of PN-associated liver injury. Time to normalize ALT and direct bilirubin were estimated using Kaplan-Meier and Cox proportional hazards methods.
RESULTS: Mean age PN cessation was 6 months (range, 2-14 months). Median PN duration was 18 weeks (interquartile range [IQR], 13-33 weeks), and median follow-up was 24 weeks (IQR, 14-48 weeks). After transition to full enteral nutrition, 74% of children normalized direct bilirubin, whereas only 50% normalized ALT. Kaplan-Meier median time to direct bilirubin and ALT normalization were 13 weeks and 35 weeks, respectively (P = .001).
CONCLUSION: Children with PNALD who have achieved PN independence have persistent ALT elevation despite normal direct bilirubin levels. This implies that hepatic injury may be ongoing beyond the time of bilirubin normalization in this cohort of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524721      PMCID: PMC4547788          DOI: 10.1016/j.jpedsurg.2009.02.011

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  19 in total

1.  Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.

Authors:  D J Andorsky; D P Lund; C W Lillehei; T Jaksic; J Dicanzio; D S Richardson; S B Collier; C Lo; C Duggan
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

2.  The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.

Authors:  Patrick J Javid; Sharon Collier; Denise Richardson; Julie Iglesias; Kathleen Gura; Clifford Lo; Heung Bae Kim; Christopher P Duggan; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2005-06       Impact factor: 2.545

Review 3.  Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

4.  Growth and development of an infant receiving all nutrients exclusively by vein.

Authors:  D W Wilmore; S J Dudrick
Journal:  JAMA       Date:  1968-03-04       Impact factor: 56.272

5.  Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy.

Authors:  B B Dahms; T C Halpin
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

Review 6.  Short-bowel syndrome in children and adults.

Authors:  J A Vanderhoof; A N Langnas
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

7.  Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition.

Authors:  S Chan; K C McCowen; B R Bistrian; A Thibault; M Keane-Ellison; R A Forse; T Babineau; P Burke
Journal:  Surgery       Date:  1999-07       Impact factor: 3.982

Review 8.  The current state of serum biomarkers of hepatotoxicity.

Authors:  Josef Ozer; Marcia Ratner; Martin Shaw; Wendy Bailey; Shelli Schomaker
Journal:  Toxicology       Date:  2007-12-05       Impact factor: 4.221

9.  Short-bowel syndrome in children. Quality of life in an era of improved survival.

Authors:  T R Weber; T Tracy; R H Connors
Journal:  Arch Surg       Date:  1991-07

Review 10.  Abnormalities of liver function and hepatic damage associated with total parenteral nutrition.

Authors:  H R Freund
Journal:  Nutrition       Date:  1991 Jan-Feb       Impact factor: 4.008

View more
  7 in total

1.  Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experience.

Authors:  Sharef W Sharef; Siham Al-Sinani; Khalid Al-Naamani; Ibrahim Al-Zakwani; Zenaida S Reyes; Hilal Al-Ryiami; Ashfaq A Khan; Watfa Al-Mamari
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

2.  Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.

Authors:  Faraz A Khan; Jeremy G Fisher; Eric A Sparks; Alexis Potemkin; Christopher Duggan; Bram P Raphael; Biren P Modi; Tom Jaksic
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

3.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

4.  The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

Authors:  Prathima Nandivada; Melissa I Chang; Alexis K Potemkin; Sarah J Carlson; Eileen Cowan; Alison A Oʼloughlin; Paul D Mitchell; Kathleen M Gura; Mark Puder
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

5.  Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.

Authors:  Shimae C Fitzgibbons; Brian A Jones; Melissa A Hull; David Zurakowski; Debora Duro; Christopher Duggan; Dana Boctor; David L Sigalet; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

6.  The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patients.

Authors:  Maria B Badia-Tahull; Elisabet Leiva-Badosa; Ramon Jodar-Masanes; Josep Maria Ramon-Torrell; Josep Llop-Talaveron
Journal:  Nutr J       Date:  2015-07-02       Impact factor: 3.271

7.  Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.

Authors:  Nisha Mangalat; Cynthia Bell; April Graves; Essam M Imseis
Journal:  BMC Pediatr       Date:  2014-12-10       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.